Analyst Research

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Acadia Healthcare Company Inc Raises FY 2013 EPS Guidance


Tuesday, 29 Oct 2013 04:00pm EDT 

Acadia Healthcare Company Inc raised fiscal 2013 guidance for adjusted earnings per diluted share (EPS) to a new range of $1.06 to $1.07 from the previous range of $1.01 to $1.03. The Company's guidance does not include transaction-related expenses, debt extinguishment costs and the impact of any future acquisitions. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $1.03 for fiscal 2013.